Mediators of the association between maternal body mass index and breastfeeding duration in 3 international cohorts.


Journal

The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027

Informations de publication

Date de publication:
07 2023
Historique:
received: 08 03 2022
revised: 07 03 2023
accepted: 03 04 2023
pmc-release: 18 05 2024
medline: 7 7 2023
pubmed: 6 7 2023
entrez: 5 7 2023
Statut: ppublish

Résumé

Maternal obesity has been associated with shorter breastfeeding duration, but little is known about mediating factors explaining this association. It is important to assess these relationships across diverse populations because breastfeeding is culturally patterned. We investigated the association of prepregnancy maternal body mass index (BMI) with breastfeeding outcomes and potential mediators of this relationship in 3 culturally diverse international cohorts. We analyzed 5120 singleton pregnancies from mother-child cohorts in Spain (INfancia y Medio Ambiente), Greece (Rhea), and the United States (Project Viva). Outcome variables were duration of any and exclusive breastfeeding. A priori hypothesized mediators in the association of maternal prepregnancy BMI with breastfeeding were birthweight (BW), maternal prenatal C-reactive protein (CRP), cesarean delivery, maternal dietary inflammatory index (DII) during pregnancy, gestational age at delivery, and gestational diabetes mellitus (GDM). We estimated the association between BMI and breastfeeding duration using linear regression adjusting for confounders. Mediation analysis estimated direct and indirect effects of maternal overweight/obesity on breastfeeding for each mediator. Women with overweight and obesity had shorter duration of any and exclusive breastfeeding compared with normal-weight women (any: overweight β = -0.79 mo, 95% CI: -1.17, -0.40; obese β = -1.75 mo 95% CI: -2.25, -1.25; exclusive: overweight β = -0.30 mo, 95% CI: -0.42, -0.16; obese β = -0.73 mo, 95% CI: -0.90, -0.55). Significant mediators (% change in effect estimate) of this association were higher CRP (exclusive: 5.12%), cesarean delivery (any: 6.54%; exclusive: 7.69%), and higher DII (any: 6.48%; exclusive: 7.69%). GDM, gestational age, and BW did not mediate the association of maternal weight status with breastfeeding. Higher prepregnancy BMI is associated with shorter duration of any and exclusive breastfeeding. Maternal dietary inflammation, systemic inflammation, and mode of delivery may be key modifiable mediators of this association. Identification of mediators provides potential targets for interventions to improve breastfeeding outcomes.

Sections du résumé

BACKGROUND
Maternal obesity has been associated with shorter breastfeeding duration, but little is known about mediating factors explaining this association. It is important to assess these relationships across diverse populations because breastfeeding is culturally patterned.
OBJECTIVES
We investigated the association of prepregnancy maternal body mass index (BMI) with breastfeeding outcomes and potential mediators of this relationship in 3 culturally diverse international cohorts.
METHODS
We analyzed 5120 singleton pregnancies from mother-child cohorts in Spain (INfancia y Medio Ambiente), Greece (Rhea), and the United States (Project Viva). Outcome variables were duration of any and exclusive breastfeeding. A priori hypothesized mediators in the association of maternal prepregnancy BMI with breastfeeding were birthweight (BW), maternal prenatal C-reactive protein (CRP), cesarean delivery, maternal dietary inflammatory index (DII) during pregnancy, gestational age at delivery, and gestational diabetes mellitus (GDM). We estimated the association between BMI and breastfeeding duration using linear regression adjusting for confounders. Mediation analysis estimated direct and indirect effects of maternal overweight/obesity on breastfeeding for each mediator.
RESULTS
Women with overweight and obesity had shorter duration of any and exclusive breastfeeding compared with normal-weight women (any: overweight β = -0.79 mo, 95% CI: -1.17, -0.40; obese β = -1.75 mo 95% CI: -2.25, -1.25; exclusive: overweight β = -0.30 mo, 95% CI: -0.42, -0.16; obese β = -0.73 mo, 95% CI: -0.90, -0.55). Significant mediators (% change in effect estimate) of this association were higher CRP (exclusive: 5.12%), cesarean delivery (any: 6.54%; exclusive: 7.69%), and higher DII (any: 6.48%; exclusive: 7.69%). GDM, gestational age, and BW did not mediate the association of maternal weight status with breastfeeding.
CONCLUSIONS
Higher prepregnancy BMI is associated with shorter duration of any and exclusive breastfeeding. Maternal dietary inflammation, systemic inflammation, and mode of delivery may be key modifiable mediators of this association. Identification of mediators provides potential targets for interventions to improve breastfeeding outcomes.

Identifiants

pubmed: 37407164
pii: S0002-9165(23)46333-2
doi: 10.1016/j.ajcnut.2023.04.004
pmc: PMC10493413
pii:
doi:

Substances chimiques

C-Reactive Protein 9007-41-4

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

255-263

Subventions

Organisme : NIEHS NIH HHS
ID : P30 ES007048
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD034568
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES029944
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES030364
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES023515
Pays : United States
Organisme : NIEHS NIH HHS
ID : R21 ES029681
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023286
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES030691
Pays : United States
Organisme : NICHD NIH HHS
ID : T32 HD098061
Pays : United States
Organisme : NIEHS NIH HHS
ID : R21 ES028903
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.

Références

Diabetes Metab. 2009 Dec;35(6):490-4
pubmed: 19897394
Paediatr Perinat Epidemiol. 2009 Sep;23(5):394-402
pubmed: 19689488
Epidemiology. 1999 Jan;10(1):37-48
pubmed: 9888278
J Clin Biochem Nutr. 2018 Jan;62(1):83-88
pubmed: 29371758
J Hum Lact. 2004 Feb;20(1):18-29
pubmed: 14974697
Int J Obes Relat Metab Disord. 2004 May;28(5):674-9
pubmed: 14993913
Breastfeed Med. 2012 Feb;7(1):43-9
pubmed: 21524193
Endocrinol Metab (Seoul). 2021 Apr;36(2):209-219
pubmed: 33866777
Pediatr Res. 2017 Mar;81(3):434-442
pubmed: 27846197
JAMA. 2001 Jan 24-31;285(4):413-20
pubmed: 11242425
Pediatrics. 2010 Jul;126(1):e18-25
pubmed: 20566605
Matern Child Nutr. 2014 Jul;10(3):335-46
pubmed: 22642318
Am J Physiol Endocrinol Metab. 2005 Jun;288(6):E1179-87
pubmed: 15671082
Pediatrics. 2012 Mar;129(3):e827-41
pubmed: 22371471
JAMA. 2013 Jun 12;309(22):2362-70
pubmed: 23757084
Nutrients. 2021 May 02;13(5):
pubmed: 34063221
J Pediatr Gastroenterol Nutr. 2019 Mar;68(3):400-407
pubmed: 30562307
Pediatr Clin North Am. 2013 Feb;60(1):31-48
pubmed: 23178059
Eur J Clin Nutr. 2018 Dec;72(12):1644-1654
pubmed: 29670258
BMJ. 2017 Feb 8;356:j1
pubmed: 28179267
Annu Rev Nutr. 2007;27:103-21
pubmed: 17341160
Nutrients. 2018 Aug 08;10(8):
pubmed: 30096771
Breastfeed Med. 2015 Jun;10(5):239-45
pubmed: 25973675
PLoS One. 2015 May 13;10(5):e0126327
pubmed: 25970502
J Epidemiol Community Health. 1992 Dec;46(6):559-65
pubmed: 1494068
JAMA. 2016 Jun 7;315(21):2284-91
pubmed: 27272580
Pediatr Obes. 2016 Dec;11(6):491-499
pubmed: 26763767
Adv Nutr. 2016 Mar 15;7(2):407-14
pubmed: 26980825
J Womens Health (Larchmt). 2015 Jul;24(7):563-71
pubmed: 25902486
Diabetes Care. 2014 Jan;37 Suppl 1:S81-90
pubmed: 24357215
Eur Child Adolesc Psychiatry. 2022 Apr;31(4):615-624
pubmed: 33398651
BMC Pregnancy Childbirth. 2020 Nov 26;20(1):734
pubmed: 33243188
Environ Health Perspect. 2017 Nov 13;125(11):117004
pubmed: 29135438
Epidemiology. 2009 Jul;20(4):496-9
pubmed: 19525686
Matern Child Nutr. 2014 Apr;10(2):166-83
pubmed: 22905677
Int J Epidemiol. 2015 Feb;44(1):37-48
pubmed: 24639442
Am J Clin Nutr. 2003 Apr;77(4):931-6
pubmed: 12663294
Matern Child Health J. 2018 May;22(5):725-734
pubmed: 29349652
Int J Environ Res Public Health. 2021 Sep 04;18(17):
pubmed: 34501944
J Paediatr Child Health. 2000 Oct;36(5):482-6
pubmed: 11036806
Br J Nutr. 2005 Oct;94(4):533-9
pubmed: 16197577
J Nutr. 2016 Apr;146(4):728-36
pubmed: 26936137
Int J Epidemiol. 2017 Oct 1;46(5):1392-1393k
pubmed: 29040580
J Nutr. 2011 Apr 1;141(4):645-53
pubmed: 21346096
Hum Reprod Update. 2010 May-Jun;16(3):255-75
pubmed: 19966268
Environ Health Perspect. 2014 Apr;122(4):378-83
pubmed: 24508979
BMC Pregnancy Childbirth. 2016 Apr 26;16:90
pubmed: 27118118
Matern Child Health J. 2019 Oct;23(10):1339-1347
pubmed: 31218609
J Obstet Gynecol Neonatal Nurs. 2020 Sep;49(5):437-451
pubmed: 32659217
Public Health Nutr. 2014 Aug;17(8):1689-96
pubmed: 23941862
Am J Obstet Gynecol. 2018 Feb;218(2S):S630-S640
pubmed: 29422205
JAMA Pediatr. 2013 Sep;167(9):836-44
pubmed: 23896931
Int J Epidemiol. 2012 Aug;41(4):930-40
pubmed: 21471022
Breastfeed Med. 2019 Jan/Feb;14(1):39-45
pubmed: 30383402
J Nutr. 2015 Sep;145(9):1999-2005
pubmed: 26203096
NCHS Data Brief. 2020 Nov;(392):1-8
pubmed: 33270551
JAMA. 1999 Dec 8;282(22):2131-5
pubmed: 10591334

Auteurs

Madeline Keyes (M)

Division of Newborn Medicine, Boston Children's Hospital, Boston, MA, United States; Harvard Neonatal-Perinatal Medicine Fellowship Program, Boston, MA, United States. Electronic address: madeline.keyes@childrens.harvard.edu.

Chloe Andrews (C)

Department of Newborn Medicine, Brigham and Women's Hospital, Boston, MA, United States.

Vishal Midya (V)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Paula Carrasco (P)

Department of Medicine, Universitat Jaume I, Castellón, Spain; Epidemiology and Environmental Health Joint Research Unit, FISABIO-Universitat Jaume I-Universitat de València, Valencia, Spain.

Mònica Guxens (M)

ISGlobal, Barcelona, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Department of Child and Adolescent Psychiatry, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands; Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Alba Jimeno-Romero (A)

Department of Preventive Medicine and Public Health, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain; Biodonostia Health Research Institute, Group of Environmental Epidemiology and Child Development, San Sebastian, Spain.

Mario Murcia (M)

Epidemiology and Environmental Health Joint Research Unit, FISABIO-Universitat Jaume I-Universitat de València, Valencia, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Servicio de análisis de sistemas de información sanitaria, Conselleria de Sanitat, Generalitat Valenciana, Valencia, Spain.

Cristina Rodriguez-Dehli (C)

Hospital San Agustin, SESPA and ISPA, Aviles, Spain.

Dora Romaguera (D)

ISGlobal, Barcelona, Spain; Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Madrid, Spain.

Loreto Santa-Maria (L)

Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain; Biodonostia Health Research Institute, Group of Environmental Epidemiology and Child Development, San Sebastian, Spain; Department of Health of the Basque Government, Subdirectorate of Public Health of Gipuzkoa, San Sebastian, Spain.

Marina Vafeiadi (M)

Department of Social Medicine, School of Medicine, University of Crete, Heraklion, Crete, Greece.

Lida Chatzi (L)

Department of Preventative Medicine, University of Southern California, Los Angeles, CA, United States.

Emily Oken (E)

Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, United States.

Martine Vrijheid (M)

ISGlobal, Barcelona, Spain.

Damaskini Valvi (D)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Sarbattama Sen (S)

Department of Newborn Medicine, Brigham and Women's Hospital, Boston, MA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH